PE20010673A1 - Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios - Google Patents

Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios

Info

Publication number
PE20010673A1
PE20010673A1 PE2000000971A PE0009712000A PE20010673A1 PE 20010673 A1 PE20010673 A1 PE 20010673A1 PE 2000000971 A PE2000000971 A PE 2000000971A PE 0009712000 A PE0009712000 A PE 0009712000A PE 20010673 A1 PE20010673 A1 PE 20010673A1
Authority
PE
Peru
Prior art keywords
allergic
desloratadine
treatment
inflammatory states
day
Prior art date
Application number
PE2000000971A
Other languages
English (en)
Inventor
Melton B Affrime
Christopher R Banfield
Samir K Gupta
Desmond Padhi
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE20010673A1 publication Critical patent/PE20010673A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

SE REFIRE AL USO DE DESLORATADINA PARA TRATAR O PREVENIR ESTADOS ALERGICOS O INFLAMATORIOS DE LA PIEL Y VIAS AEREAS COMO RINITIS ALERGICA, DERMATITIS ATOPICA O URTICARIA; EVITA EL EFECTO DE LOS ALIMENTOS ASOCIADOS CON LA ANTIHISTAMINA NO SEDATIVAS; UTILIZANDOSE DE 2,5mg/DIA A 45mg/DIA
PE2000000971A 1999-09-21 2000-09-19 Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios PE20010673A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40014799A 1999-09-21 1999-09-21

Publications (1)

Publication Number Publication Date
PE20010673A1 true PE20010673A1 (es) 2001-06-30

Family

ID=23582412

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000971A PE20010673A1 (es) 1999-09-21 2000-09-19 Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios

Country Status (8)

Country Link
US (1) US20040138247A1 (es)
EP (1) EP1214072A2 (es)
JP (1) JP2003509458A (es)
AR (1) AR025711A1 (es)
AU (1) AU7704200A (es)
CA (1) CA2383211A1 (es)
PE (1) PE20010673A1 (es)
WO (1) WO2001021161A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405223B2 (en) * 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
JP4950063B2 (ja) * 2004-12-22 2012-06-13 シェーリング コーポレイション 薬学的製剤
CN113230235B (zh) * 2021-04-15 2022-11-11 海南普利制药股份有限公司 含地氯雷他定的复方缓释胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570306B2 (en) * 1984-02-15 1988-03-10 Schering Corporation 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts.
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
US5900421A (en) * 1997-02-11 1999-05-04 Sepracor Inc. Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine
EP1154762B1 (en) * 1999-02-23 2003-11-05 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
HUP0204048A3 (en) * 2000-02-03 2004-07-28 Schering Corp Use of desloratadine for treating allergic and inflammatory conditions

Also Published As

Publication number Publication date
WO2001021161A2 (en) 2001-03-29
JP2003509458A (ja) 2003-03-11
WO2001021161A3 (en) 2002-01-17
EP1214072A2 (en) 2002-06-19
AU7704200A (en) 2001-04-24
US20040138247A1 (en) 2004-07-15
CA2383211A1 (en) 2001-03-29
AR025711A1 (es) 2002-12-11

Similar Documents

Publication Publication Date Title
DK1543011T3 (da) Thienopyrrolyl- og furanopyrrolylforbindelser og deres anvendelse som histamin H4-receptorligander
CY1121135T1 (el) Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
MX2009001327A (es) Compuestos de indol.
NO20074943L (no) Roflumilast for behandlingen av diabetes mellitus
UY28970A1 (es) Compuestos moduladores de la actividad de c-kit y usos de los mismos
NO20072665L (no) Rapamycinderivater og deres anvendelse i behandling av nevrologiske lidelser
ATE409188T1 (de) Naphthyridinverbindungen
HK1080467A1 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
DE69732868D1 (de) Mittel gegen Juckreiz
CL2008003407A1 (es) Compuestos derivados de aril- y heteroarilcarbonilo de heterobiciclo sustituido; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento y/o prevencion de trastornos metabolicos, mediado por la inhibicion de la enzima hsd-1.
GB0504828D0 (en) Therapeutic agents
BRPI0517015A (pt) compostos e composições como inibidores de atividade de receptor 1 de canabinóide
SG170813A1 (en) New compounds
NO20052591L (no) Pyridopyrolizin og pyridoindolizinderivater
CR8928A (es) Derivados arilsulfonilestilbeno para tratamiento de insomnio y afecciones relacionadas
ATE477805T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
DK1423384T3 (da) Pyridinderivater som Raf kinaseinhibitorer
NO20092073L (no) Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav
CY1114989T1 (el) ΠΑΡΑΓΩΓΑ ΤΗΣ ΠΥΡΙΔΟ[2,3-d]ΠΥΡΙΜΙΔΙΝΗΣ, Η ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ ΚΑΙ Η ΕΦΑΡΜΟΓΗ ΤΟΥΣ ΣΕ ΘΕΡΑΠΕΥΤΙΚΕΣ ΑΓΩΓΕΣ
UY29109A1 (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios
ATE534649T1 (de) Imidazothiazole und imidazoxazolderivative als inhibitoren von p38
UA99901C2 (en) Indole compounds
PE20010673A1 (es) Uso de desloratadina para el tratamiento de estados alergicos e inflamatorios

Legal Events

Date Code Title Description
FC Refusal